A proposal to cap provider prices and price growth in the commercial health-care market Michael E. Chernew, Leemore Dafny, and Maximilian Pany Tuesday, March 10, 2020
2018 Jul 18 Past Event Cultivating a vibrant U.S. market for biosimilars: A conversation with FDA’s Scott Gottlieb 1:30 PM - 3:00 PM EDT Washington, DC
